ABCB1 and familial pancreatic carcinoma: Reed et al provided strong evidence that changes in ABCB1 promoter methylation were associated with drug resistance in breast tumor cells.36 However, other studies reported that ABCB1 expression was altered in pancreatic cancer with drug resistance by a mechanism independent of promoter methylation.37